Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM(197) conjugate vaccine co-localizes with MHC II on the antigen processing cell surface (Q41938395)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 April 2009

Language	Label	Description	Also known as
English	Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM(197) conjugate vaccine co-localizes with MHC II on the antigen processing cell surface	scientific article published on 10 April 2009

Statements

scholarly article

1 reference

Europe PubMed Central

14 October 2017

Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM(197) conjugate vaccine co-localizes with MHC II on the antigen processing cell surface (English)

1 reference

Europe PubMed Central

14 October 2017

1 reference

based on heuristic

inferred from title

author name string

Zengzu Lai

1

1 reference

Europe PubMed Central

14 October 2017

John R Schreiber

2

1 reference

Europe PubMed Central

14 October 2017

language of work or name

0 references

publication date

10 April 2009

1 reference

Europe PubMed Central

14 October 2017

1 reference

Europe PubMed Central

14 October 2017

27

1 reference

Europe PubMed Central

14 October 2017

24

1 reference

Europe PubMed Central

14 October 2017

3137-3144

1 reference

Europe PubMed Central

14 October 2017

Polysaccharide processing and presentation by the MHCII pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Antibody response to pneumococcal vaccination in children younger than five years of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

T cell-independent antigens type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

T-cell hybridoma specific for a cytochrome c peptide: specific antigen binding and interleukin 2 production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Antigen presentation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Antigen processing of the heptavalent pneumococcal conjugate vaccine carrier protein CRM(197) differs depending on the serotype of the attached polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Structural requirements for in vivo and in vitro immunogenicity in hapten-specific delayed hypersensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Thymus-independent and thymus-dependent responses to polysaccharide antigens

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with meningococcal polysaccharide-tetanus toxoid conjugate induces polysaccharide-reactive T cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

T-cell recognition of non-peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.064

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.03.064

1 reference

Europe PubMed Central

14 October 2017

1 reference

Europe PubMed Central

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41938395&oldid=1930082874"